Occupational asthma
work-related airways · Respiratory
Physician-written · Verified by three sets of doctors · Reviewed November 2026
Bedside summary
Occupational asthma is new-onset asthma caused by a workplace sensitiser (e.g. isocyanates, flour, latex) or irritant exposure. Early diagnosis and removal from exposure are critical because persistence worsens prognosis and symptoms may continue even after cessation.
Red flags
- Severe exacerbation after workplace re-exposure
- Progressive symptoms despite controller therapy
- Co-workers similarly affected (points to a cluster)
- Anaphylaxis to high-molecular-weight agent (e.g. latex)
Assessment
Differential diagnosis
- Work-exacerbated pre-existing asthma
- Irritant-induced asthma / reactive airways dysfunction syndrome
- Hypersensitivity pneumonitis
- Rhinitis without asthma
- Building-related non-specific symptoms
Investigations
- Detailed occupational and exposure history with timeline relative to symptoms
- Serial peak expiratory flow monitoring at and away from work (>=4x/day, 3-4 weeks)
- Spirometry with reversibility and non-specific bronchial challenge
- Specific IgE / skin-prick testing to workplace allergen where available
- Specific inhalation (bronchial provocation) challenge in a specialist centre (gold standard)
- FeNO and blood eosinophils
Management
- Take a structured occupational history linking symptoms to work and relief on holidays/weekends
- Identify the specific agent and whether it is a sensitiser or irritant
- Arrange serial PEF monitoring across work and rest periods and interpret with occupational tools
- Confirm immunological sensitisation where a test exists
- Refer to an occupational lung disease specialist for definitive testing
- Remove the worker from exposure as early as possible once confirmed
- Treat the asthma with standard inhaled controller therapy
- Advise on redeployment, respiratory protection and workplace control measures
- Report to the relevant occupational disease authority and support compensation claims
- Monitor long term as airway responsiveness may persist despite exposure cessation
Drugs & doses
ICS-LABA e.g. beclometasone-formoterol 100/6 mcg 2 puffs twice daily
Salbutamol 100 mcg 2 puffs as reliever
Prednisolone 40 mg PO daily short course for exacerbations
Disposition
Occupational lung disease clinic; statutory reporting; workplace exposure control and potential redeployment.
Complications & pitfalls
- Persistent asthma despite removal from exposure
- Loss of employment and income
- Fixed airflow obstruction
- Progression to severe asthma
Exam pearls
- Earlier removal from exposure gives the best chance of recovery
- A normal challenge off-work does not exclude occupational asthma — test near exposure
- Isocyanates (spray painting, polyurethane) are a leading cause
- Latex and flour/enzyme exposures are classic high-molecular-weight causes
Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.